Chair
Jacques Galipeau, MD, FRCP (C), Associate Dean for Therapeutics Development, University of Wisconsin in Madison
Speakers
Mark Lowdell, PhD, Chief Scientific Officer, INmuneBio Inc
Bruce Levine, PhD, Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania
Anna Sureda, MD, PhD, Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals (Barcelona)
To launch the ISCT 2023 Paris Translational Pathway Program, ISCT President Jacques Galipeau is excited to present La Présidentielle, a deep dive into The Future of Immune Effector Cell Therapies for Cancer, featuring Society leaders at the very forefront of the cancer immunotherapy field.
This opening session will explore the state of the art in chimeric antigen receptor (CAR) based therapies and other novel technologies for liquid and solid cancers and address persistent and emerging barriers to the successful adoption of these advanced therapies globally.
Associate Dean for Therapeutics Development
University of Wisconsin in Madision
Chair
Barbara and Edward Netter Professor in Cancer Gene Therapy
University of Pennsylvania
Speaker
Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme
Institut Català d'Oncologia - Hospital Duran i Reynals (Barcelona)
Speaker